-
-
-
-
-
-
-
Resolutions from Zealand Pharma's Annual General Meeting 2025
-
-
-
-
-
-
-
Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion
-
-
-
-
-
-
-
Zealand Pharma announces completion of a directed issue and private placement of 4,975,000 new ordinary shares raising gross proceeds of approx. DKK 786 million
-
-
-
-
-
-
-
Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Go® Insulin Delivery Device
-
-
-
-
-
-
-
Zealand Pharma's Annual General Meeting 2022
-
-
-
-
-
-
-
Zealand Pharma Presents Financial Results for the First Nine Months of 2021; Provides Updates on Commercial Launch and Timing for Congenital Hyperinsulinism and Short Bowel Syndrome Phase Three Clinic
-
-
-
-
-
-
-
Zealand Pharma A/S – Transaction Under Share Repurchase Program
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

